Ibrutinib in the Treatment of Chronic Lymphocytic Leukemia
DOI:
https://doi.org/10.21320/2500-2139-2017-10-3-interview-IbrutinibInterviewer: Prof. E.A. Osmanov, DSci
- -
License
Copyright (c) 2017 Clinical Oncohematology
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Downloads
Download data is not yet available.
Downloads
Published
01.07.2017
Issue
NOVEL DRUGS
How to Cite
Ibrutinib in the Treatment of Chronic Lymphocytic Leukemia. Clinical Oncohematology. Basic Research and Clinical Practice. 2017;10(3):282–286. doi:10.21320/2500-2139-2017-10-3-interview-Ibrutinib.
